viewVodafone Group plc

Vodafone offers AWS 'edge computing' to business customers

Edge computing is said to increase privacy and speeds over the cloud

Vodafone Group plc -

Vodafone Group plc (LON:VOD) has teamed up with Amazon Inc (NASDAQ:AMZN) to offer ‘edge computing’ capabilities for its business customers in Europe.

Edge computing is where devices, which are running software on the cloud, take on key parts of the computing and processing in order to increase privacy and reduce latency, ie the time it takes for data to be sent from one point to another. 

READ: Vodafone returns to growth in Q2, profits hit by India ruling

Amazon Web Services (AWS) will provide its AWS Wavelength service, which Vodafone said will offer ultra-low latency for business customers that need it for applications from artificial intelligence, augmented and virtual reality to video analytics, autonomous vehicles, robotics and drone control.

With edge computing capabilities developers can build applications on the AWS platform that serve end users with single-digit millisecond latencies over the 5G network.

“Faster speeds and lower latencies have the potential to revolutionize how our customers do business, and they can rely on Vodafone's existing capabilities and security layers within our own network,” said Vinod Kumar, chief executive of Vodafone Business.

AWS Wavelength will be available first to business customers in the UK and Germany on the Vodafone 5G network, expanding to other markets across Europe.

Quick facts: Vodafone Group plc

Price: 112.4255 GBX

Market: LSE
Market Cap: £30.11 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Sareum Holdings new licensing deal 'could generate significant near-term...

Sareum Holdings PLC's (LON:SAR) Tim Mitchell speaks to Proactive's Andrew Scott soon after announcing a licensing deal with an unnamed Chinese specialty pharmaceutical company. The firm will develop Sareum's FLT3+Aurora kinases portfolio, including SAR-20293, a preclinical drug candidate for...

1 hour, 38 minutes ago

2 min read